A randomised feasibility trial of high water intake in polycystic kidney disease (DRINK)
Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic condition where fluid-filled sacs, called cysts, grow on the kidneys. Over time, these cysts can cause kidney damage and high blood pressure. A natural brain hormone called vasopressin helps control body water, but it also causes these kidney cysts to grow. When you drink lots of water, your body stops making vasopressin. The DRINK study is testing whether drinking prescribed amounts of extra water—usually between 2 and 4 litres each day—is practical and helpful for people with ADPKD. Participants will be placed into one of two groups for eight weeks: one group drinks extra water, while the other drinks their normal amounts. Both groups will attend clinic visits for regular health checks, blood tests, and urine tests. The goal is to see if this simple habit could protect kidneys in the future.
A colpo d'occhio
Di cosa tratta questo studio?
Autosomal dominant polycystic kidney disease (ADPKD) is an inherited condition that affects around 1 in every 800 people across the UK. Over time, small fluid-filled pockets called cysts develop and swell inside the kidneys. As these cysts expand, they can damage healthy kidney tissue. This often leads to high blood pressure and can eventually cause kidney failure, meaning someone might need dialysis or a kidney transplant later in life.
Doctors have discovered that a natural hormone in the body, called vasopressin, plays a major part in this condition. Your brain makes vasopressin when you are thirsty to help your kidneys save water. However, in people with ADPKD, this hormone also triggers the cysts to multiply and fill with more fluid. When you drink plenty of water, your body naturally switches off vasopressin production and creates pale, diluted urine.
The DRINK trial was designed to find out if drinking high amounts of water is a safe and practical everyday approach to slow cyst growth. By asking patients to drink a set amount of water each day, researchers hope to see if naturally lowering vasopressin levels could become an easy, low-cost way to protect kidney health in the long run.
Punti chiave
- Tests whether drinking more water can lower the hormone that makes kidney cysts grow.
- Designed for people aged 16 and over with polycystic kidney disease (ADPKD).
- Involves 8 weeks of either drinking extra water or drinking your usual amounts.
- Requires six hospital visits in total for standard health, blood, and urine checks.
- Taking part is voluntary, and you can withdraw at any time without affecting your normal care.
Chi può essere idoneo?
This trial is open to adults and teenagers aged 16 and over who have been diagnosed with ADPKD. To take part, your kidneys must still be working at a moderate level (an eGFR score of 20 or above). You also need to be willing and able to test your own urine at home using simple dipstick tests to check how diluted it is.
You cannot take part if your kidney function is too low (eGFR below 20) or if you have other medical problems that affect fluid balance, such as heart failure or liver disease. People with diabetes, certain other kidney conditions, or those who are pregnant or breastfeeding are also unable to join.
Additionally, if you take water tablets (diuretics) for fluid build-up, or if you have taken a kidney medicine called tolvaptan in the past four weeks, you will not be able to join. However, people taking water tablets solely for high blood pressure may be able to join after a brief two-week check period.
Questo studio potrebbe fare al caso tuo?
Rispondi a queste domande rapide per vedere se potresti essere idoneo. Questo è solo una guida — il team di ricerca prende la decisione finale.
- I am aged 16 or older.
- I have a confirmed diagnosis of autosomal dominant polycystic kidney disease (ADPKD).
- My kidney function is at a safe level (eGFR of 20 or higher).
- I do not have heart failure, liver cirrhosis, or diabetes.
- I have not taken the kidney medication tolvaptan in the last four weeks.
- I am not pregnant or breastfeeding.
Cosa comporta la partecipazione?
If you take part, you will be randomly placed into one of two groups by chance, like flipping a coin. One group will receive a tailored water plan, asking them to drink extra water (usually 2 to 4 litres per day) for eight weeks to keep their urine diluted. The second group will carry on drinking their normal amounts of fluid as usual.
Over the 8-week study, you will visit the hospital clinic five times, followed by one final visit four weeks after the drinking phase ends. This means the study lasts around 12 weeks in total. During these visits, the study team will review your diet and general health, check your blood pressure, run routine blood and urine tests, and ask you to fill out short questionnaires about how you feel.
There are no experimental drugs to take in this study. If you are in the high-water group, your main task will simply be drinking your prescribed amount of water each day and testing your urine concentration at home.
Rischi e benefici potenziali
Luoghi (1)
- Addenbrookes HositalSolo cittàCambridge, England
Domande comuni
Devo prendere nuove medicine?
No. The study only looks at the effects of drinking water, so there are no trial drugs involved.
How much extra water will I need to drink?
If you are put into the high-water group, your team will give you a personal target, usually between 2 and 4 litres of water spread across each day.
Can I choose which group I am in?
No. A computer randomly selects your group to keep the research completely fair and unbiased.
How do I test my own urine at home?
The study team will provide simple testing strips that you dip into your urine to check if it is light and dilute enough.
What happens if I cannot manage to drink the full amount?
You should simply let the research team know. Part of this study is finding out whether drinking this much water is manageable in everyday life.
Come saperne di più
Ragada El-Damanawi
Parla sempre con il tuo medico di base o specialista prima di decidere di partecipare a uno studio.
Discussione
Discussione della comunità
Supportato dal nostro forum su community.patient.info. Si prega di essere rispettosi — questo non è un consiglio medico.